DIAGNOSIS OF COGNITIVE IMPAIRMENT IN PATIENTS WITH CHRONIC CEREBROVASCULAR DISEASE AND TYPE 2 DIABETES MELLITUS

DOI: https://doi.org/10.29296/25877305-2022-04-11
Issue: 
4
Year: 
2022

M. Belokopytova; Associate Professor I. Dolgova, MD; Professor V. Baturin, MD; S. Ermakov
Stavropol State Medical University

Objective. To evaluate the effectiveness of a comprehensive examination algorithm, to determine important diagnostic features that predict the development of different severity of cognitive impairment (CI) in patients with type 2 diabetes mellitus (DM2). Subjects and methods. The investigation enrolled 81 patients with chronic cerebrovascular disease and DM2. They were divided into 3 groups: 1) 34 patients with mild CI and Stage I diabetic encephalopathy (DE) (a study group); 2) 23 patients with moderate CI and Stage II DE (a study group); 3) 24 patients without CI (a control group). Clinical, anamnestic, neuroimaging, and neurophysiological data were investigated in the study groups of patients with Stages I and II DE. The severity of CI was defined according to the neuropsychological testing data. Results. The total load with the diagnostic signs characteristic of DE increased in the group of Stage II DE patients with moderate CI, which is confirmed by statistical data. The severity of CI in patients with DM2 increased with the concurrence of the duration of DM2, a patient’s age, and the atrophic signs of brain substance, the presence of postischemic cysts, and stenotic lesions of the brachiocephalic arteries.

Keywords: 
Key words: endocrinology
neurology
type 2 diabetes mellitus
diabetic encephalopathy
cognitive impairment
diagnosis.



References: 
  1. Ostroumova O.D., Surkova E.V., Chikh E.V. et al. Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs. Diabetes mellitus. 2018; 21 (4): 307–18 (in Russ.). DOI: 10.14341/DM9660
  2. Samoilova I.G., Rotkank M.A., Zhukova N.G. et al. Variability of glycemia in patients with type 1 diabetes mellitus: the relationship with cognitive dysfunction and the results of magnetic resonance imaging. Problems of Endocrinology. 2018; 64 (5): 286–91 (in Russ.). DOI: 10.14341/probl9589
  3. Shishkova V.N. Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention. Ter Arkh. 2015; 87 (1): 109–14 (in Russ.). DOI: 10.17116/terarkh2015871109-114
  4. Elham Saedi, Mohammad Reza Gheini, Firoozeh Faiz et al. Diabetes mellitus and cognitive impairments. World J Diabetes. 2016; 7 (17): 412–22. DOI: 10.4239/wjd.v7.i17.412
  5. Chang Li, Jingna Zhang, Mingo Qiu et al. Changes in the structural network connectivity of the brain in patients with type 2 diabetes mellitus with moderate cognitive impairment Anterior aging neuroses. 2020 Changes in structural network connectivity in the brain in patients with type 2 diabetes mellitus with mild cognitive impairment. Front Aging Neurosci. 2021; 12: 615048. DOI: 10.3389/fnagi.2020.615048
  6. Chukanova E.I., Chukanova A.S. Chronic cerebral ischemia, neuroplasticity, possibilities of therapy. Neurology, Neuropsychiatry, Psychosomatics. 2017; 9 (2): 102–7 (in Russ.). DOI: 10.14412/2074-2711-2017-2-102-107